Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Interventional × glembatumumab vedotin × Clear all

Phase

Phase 2 4 Phase 1/2 2 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 51 Cyclophosphamide 49 pembrolizumab 35 fludarabine 33 Radiotherapy 27 Biopsy 24 Nivolumab 22 Metformin 20 Bevacizumab 20 Fluorodeoxyglucose F18 19 Specimen Handling 17 Cisplatin 14 Temozolomide 13 Radiosurgery 13 Carboplatin 13 Paclitaxel 12 Fluorouracil 12 Dexamethasone 12 durvalumab 11 Radiation 11 gallium 68 PSMA-11 10 Rituximab 10 Letrozole 10 Gemcitabine 10 Etoposide 10 Doxorubicin 10 atezolizumab 9 X-Rays 9 Standard of Care 9 Irinotecan 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03473691 2024-12-09

Breast50

University of Virginia

Phase EARLY_PHASE1 Withdrawn

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡